Pl. Katzman et al., SERUM-LIPID PROFILE DETERMINES PLATELET REACTIVITY TO NATIVE AND MODIFIED LDL-CHOLESTEROL IN HUMANS, Thrombosis and haemostasis, 71(5), 1994, pp. 627-632
The effects of thrombin (0.2 U/ml) and native (n-LDL), malondialdehyde
-modified (MDA-LDL) and auto-oxidized (ox-LDL) low-density lipoprotein
s (20 mu g of protein/ml) on platelet activation were evaluated in sev
en hyperlipidemic patients and compared to seven controls (Easting ser
um cholesterol 8.49 +/- 0.5 and 4.61 +/- 0.4 mM, respectively). Basal
and thrombin-induced increases in platelet intracellular free calcium
ion concentration ([Ca2+](i); fura-2) were similar in hyperlipidemic p
atients and controls (45 +/- 5 vs 42 +/- 3 and 635 +/- 51 vs 599 +/- 6
9 mM, respectively). n-LDL, MDA-LDL and ox-LDL increased basal [Ca2+](
i) (16, 36 and 81 percent, p < 0.01 between LDL-types), increases were
consistently smaller in patients. There was an inverse relationship b
etween LDL-induced responses and fasting serum LDL cholesterol as well
as LDL/HDL ratio.In conclusion, modified LDL activated platelets to a
greater extent than n-LDL, suggesting different types of LDL-receptor
s. Their agonistic effect was inversely related to the fasting serum l
ipid profile, suggesting that blunting of platelet responses to LDL co
uld represent a protective mechanism in hyperlipidemic patients.